[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@WallStSai Avatar @WallStSai S A I ™️

S A I ™️ posts on X about $vktx, $xbi, $abvx, $nvo the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks #5158 finance XXXXX% currencies #2557 technology brands XXXX% social networks XXXX% cryptocurrencies XXXX% travel destinations XXXX%

Social topic influence $vktx #19, $xbi #16, $abvx #4, $nvo #81, $lly #5, $pfe #67, $gpcr #16, $azn #2, $bmy #9, $mrk #38

Top accounts mentioned or mentioned by @bioinvestor24 @pjamess69 @askfinvest @doepkemichel @stockgutter @andre_agtc @troytiger @pacha_8x @aggregategains @doodaddoctor @seekingalpha @semodough @pcmbio @andybradley93 @mitchmartan98 @lelounge @timcarmichael3 @bavariaron @tbbtrades @doctorsalomon

Top assets mentioned Viking Therapeutics, Inc (VKTX) Bitcoin Incognito (XBI) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Bristol-Myers Squibb Co (BMY) Merck & Co., Inc. (MRK) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Viking Holdings Ltd (VIK) AltLayer (ALT) Metsera, Inc. Common Stock (MTSR) Gilead Sciences, Inc. (GILD) AbbVie Inc (ABBV) Cidara Therapeutics, Inc. (CDTX) Exact Sciences Corp (EXAS) Arcblock (ABT) Biogen Inc (BIIB) Amgen, Inc. (AMGN) The Official XX Coin (67) Goldman Sachs (GS) Synthetify (SNY) Intra-Cellular Therapies Inc. (ITCI)

Top Social Posts

Top posts by engagements in the last XX hours

"$PFE $NVO $MTSR A judge denied Pfizer Inc.s request to temporarily block Novo Nordisk A/S $XX billion bid to acquire the obesity startup Metsera Inc. saying the US pharmaceutical companys objections to the deal dont warrant a delay"
X Link 2025-11-05T21:34Z 7752 followers, 8269 engagements

"$ABVX Its pretty normal for any pre commercial company to have very minimal to no hiring. Hiring doesnt matter for M&A. Look $EXAS Exact Sciences has 100+ job openings even today after $ABT Abbotts $20B+ acquisition"
X Link 2025-11-23T22:19Z 7752 followers, 3979 engagements

"$NVO DOWN XX% $BIIB UP 5%"
X Link 2025-11-24T11:28Z 7754 followers, 4285 engagements

"$NVO Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs $XBI $LLY $VKTX $AMGN $PFE $BMY"
X Link 2025-12-04T11:48Z 7752 followers, 2079 engagements

"$VKTX Viking Therapeutics features on CNBC Fast money segment for about three minutes. Basically they said todays ruling by FDA is a fast track for $VKTX allows them to ramp up the drug approval process $XBI"
X Link 2025-12-04T23:25Z 7752 followers, 13K engagements

"$BMY Bristol Myers must face $XXX billion lawsuit over delayed cancer drug US judge rules Bristol Myers accused of delaying FDA approvals for three drugs Lawsuit linked to $XXXX billion Celgene acquisition"
X Link 2025-12-02T03:26Z 7794 followers, 42K engagements

"$XBI Why $NVO Novo Nordisk may look to acquire $VKTX Viking Therapeutics $NVO Novo is aggressively pursuing M&A after losing the $MTSR Metsera bid and needs a dual-agonist to compete with $LLY Eli Lilly 🔹 Dual Agonism (GLP-1/GIP) $NVO Novo Nordisk's current successful drugs (Wegovy Ozempic) are single GLP-1 agonists. $VKTX Viking's VK2735 is a dual GLP-1/GIP agonist the same mechanism as Eli Lilly's Zepbound/Mounjaro which has shown highly competitive efficacy data. Acquiring $VKTX would immediately provide $NVO Novo Nordisk with a powerful next-generation dual-action molecule to compete"
X Link 2025-12-03T06:39Z 7794 followers, 45.9K engagements

"Looks like $ABVX not presenting at JPM"
X Link 2025-12-09T23:31Z 7794 followers, 10.9K engagements

"$ALT MASH data release looks imminent this week"
X Link 2025-12-08T19:38Z 7794 followers, 2371 engagements

"$AZN Aggresive Dec19 XXXX puts bought into close $ABVX M&A deal on cards"
X Link 2025-12-08T20:37Z 7794 followers, 8811 engagements

"@mroliverbarnes Brother I certainly assume FT biotech M&A scoop is already in works 😀 European company and hope you are on top of the coverage 👍🏼 $ABVX $AZN"
X Link 2025-12-08T23:43Z 7794 followers, 4254 engagements

"@adamfeuerstein So should we wait till Goldman Sachs conference for buyout 😜"
X Link 2025-12-10T01:29Z 7794 followers, 1118 engagements

"$ALT ALTIMMUNE CEO TO STEP DOWN EFFECTIVE JAN X PEMVIDUTIDE 48WK MASH DATA DUE Q4 2025"
X Link 2025-12-01T13:33Z 7791 followers, 1507 engagements

"$MRK $XBI MERCK LOOKS TO RAISE UP TO $X BILLION FROM US DOLLAR BOND SALE"
X Link 2025-12-01T14:48Z 7791 followers, 7696 engagements

"$ABBV Abbvie CFO says they will continue to look for M&A transactions in obesity space and they are not finished with Gubra transaction $XBI $VKTX $LLY $NVO $GPCR"
X Link 2025-12-03T17:01Z 7792 followers, 9275 engagements

"@bioinvestor24 @maziardoustdar $ABBV may partner with $VKTX for VK2809 as well who knows 🤷🏻♂"
X Link 2025-12-03T19:52Z 7794 followers, XXX engagements

"@ResearchPulse1 @Pharmdca It wont be an issue. $PFE put in pressure using political influence on FTC. $NVO will not have any issues acquiring $VKTX as it has got multiple items in their pipeline like MASH and XAD as well apart from GLP1. Why only buyout Why not partnerships"
X Link 2025-12-03T21:49Z 7773 followers, XXX engagements

"$VKTX There is that squeeze Flow speaks. Buyout Rumors"
X Link 2025-12-04T15:20Z 7791 followers, 26.1K engagements

"$MDGL Mardi Dier CFO of Madrigal Pharmaceuticals spotlights the company's latest quarter and the launch of their first product. She talks about Madrigal's drug sales the company's balance sheet international expansion and an extended patent. $XBI"
X Link 2025-12-04T22:43Z 7773 followers, 3349 engagements

"Looks like $GPCR GLP-1 data release is imminent on monday. Lots of options positioning today. $XBI $VKTX $LLY $NVO"
X Link 2025-12-05T16:23Z 7792 followers, 14.5K engagements

"$GPCR GLP-1 36wk ph2b $ALT MASH 48wk ph2 $XBI data on deck next week possibly which ones will succeed/fail Also M&A weekend time Bring those deal rumors back on Lot of M&A firepower with big pharma especially $BMY $AZN $GILD $MRK $PFE"
X Link 2025-12-05T20:01Z 7791 followers, 4601 engagements

"@bioinvestor24 They better drop out their drug and buy $VKTX instead 😜"
X Link 2025-12-06T02:41Z 7772 followers, XXX engagements

"$XBI This bidding process clearly shows how desperate big pharma is right now to replace LOEs and Patent Expirations. If you put away $MRK there are still five different big pharma companies who participated in a bid to acquire $CDTX. They all should have decent M&A fire power and may acquire other smaller biotech companies down the line in a short timeframe. Just recently biotech sector witnessed bidding war between $PFE and $NVO to acquire $MTSR The annual J.P. Morgan Healthcare Conference (JPM) served as a powerful catalyst for Mergers and Acquisitions (M&A) activity in the biotech sector"
X Link 2025-12-06T03:11Z 7778 followers, 6338 engagements

"$ABVX Who will it be $AZN or $SNY"
X Link 2025-12-08T20:19Z 7794 followers, 5240 engagements

"@bioinvestor24 $ITCI also presented at JPM this year but got bought out just a day before JPM conference has started. So no big deal we can get acquired anytime. $MDGL is my hot favorite for buyout now"
X Link 2025-12-10T00:23Z 7794 followers, XXX engagements

"@A_May_MD Adam - You are absolutely right You have a very valid point. Who will just throw away $4M in OTM options calls that too $XX away current stock price strikes that too just one week to expiration Very obvious its a buyout positioning just before the deal gets announced"
X Link 2025-12-10T00:57Z 7794 followers, XXX engagements

"$CDTX Big Options flow detected on 11/10 and Buyout deal announced 11/14. Unusual Flow always knows $ABVX Options flow is also in the same boat. With no catalysts events presentations and data who would buy deep OTM calls worth $4M expiring in one week"
X Link 2025-12-10T01:47Z 7794 followers, 6346 engagements

"$ABVX CEO Marc de Garidel is good at making M&A deals he led two biotech deals below. At the same time he worked for $LLY Eli Lilly as well 🔹 Sale of CinCor Pharma to AstraZeneca. 🔹 Sale of Corvidia Therapeutics to Novo Nordisk"
X Link 2025-12-10T04:08Z 7794 followers, 7396 engagements

"$ABVX ABIVAX POPS XX% ON MARKET TALK ABOUT $LLY ELI LILLY TAKEOVER INTEREST - REUTERS Two traders citing market speculation about potential takeover interest from Eli Lilly. Abivax and Eli Lilly were not immediately available for comment"
X Link 2025-12-10T10:07Z 7794 followers, 7005 engagements